Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03075631 · ClinicalTrials.gov registry record

Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences 2

A clinical trial of Pancreatitis, sponsored by University of Pittsburgh.

Completed
Registry status
1,183
Enrollment target
1
Study location

NCT03075631: Completed study of Pancreatitis, sponsored by University of Pittsburgh.

NCT03075631 is a study of Pancreatitis that has completed, run by University of Pittsburgh. The registered enrollment target is 1,183 participants, above the 553-participant average among 17 other Pancreatitis trials with a reported enrollment target (114% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03075631, a study of Pancreatitis, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
1,183 participants
Enrollment target
1
Study location

Study Summary

This study is an ancillary of APPRENTICE. This will be the international based study.

Primary Outcome

Evaluation of the existing risks, predictive scores, and markers of severe disease.

Conditions Studied

Interventions

  • OTHER Questionnaire

Study Locations (1)

Pennsylvania

  • UPMC Presbyterian - Pittsburgh

Trial Details

FieldValue
Enrollment Target 1,183 participants
Start Date 2015-12
Est. Completion 2020-03-04
University of Pittsburgh

1,238 total trials

What the finished NCT03075631 record still lists

NCT03075631 is an observational study that tracks outcomes without assigning an intervention. Its 1,183 participants enrollment target places it among the larger protocols in the corpus, above the 553-participant average among 17 other Pancreatitis trials with a reported enrollment target (114% higher).

The record links to 1 condition, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.

NCT03075631 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03075631 about?

NCT03075631 is a clinical study titled "Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences 2". This study is an ancillary of APPRENTICE. This will be the international based study.

What is the current status of trial NCT03075631?

This trial is currently completed. The enrollment target is 1,183 participants. The study started on 2015-12. Estimated completion is 2020-03-04.

What conditions does trial NCT03075631 study?

This clinical trial studies the following conditions: Pancreatitis.

What interventions are being tested in trial NCT03075631?

The interventions under investigation include: Questionnaire (OTHER).

Who is sponsoring clinical trial NCT03075631?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03075631 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03075631's enrollment target sits among peer trials

1,183 4th of 17 higher than 14 of 17 other Pancreatitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07286058 · 1,182 participants · Phase 3

    Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • NCT05580419 · 1,188 participants · NA

    Impact of 4PCP on Practitioner and Patient Outcomes

  • NCT06290869 · 1,188 participants · Phase 3

    Tobacco Education and Lung Health Study (TEAL)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03075631, the US trial registry maintained by the National Library of Medicine. NCT03075631 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.